Company Filing History:
2 out of 1,603 
6 out of 832,761 Years Active: 1978-1993
Title: The Innovations of Andre Stoll
Introduction
Andre Stoll is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit cardioselective properties. With a total of 8 patents to his name, Stoll's work has the potential to impact therapeutic practices significantly.
Latest Patents
Stoll's latest patents include innovative compounds such as 3-aminopropoxyphenyl derivatives. These compounds are characterized by their ability to elicit highly cardioselective beta 1 adrenoceptor blockade, which is crucial for developing targeted cardiovascular therapies. The preparation of these compounds involves a process known as 3-amino-2-oxypropylation of the respective substituted phenol. The resulting compounds and their physiologically hydrolysable derivatives can serve as effective therapeutic agents, showcasing Stoll's commitment to advancing medical science.
Career Highlights
Throughout his career, Andre Stoll has worked with prominent companies, including Sandoz GmbH. His experience in the pharmaceutical industry has allowed him to collaborate with other experts and contribute to groundbreaking research. Stoll's dedication to innovation is evident in his extensive patent portfolio, which reflects his ability to translate scientific concepts into practical applications.
Collaborations
Stoll has collaborated with notable individuals in his field, including William J. Louis and Richard Berthold. These partnerships have fostered an environment of creativity and innovation, leading to the development of new therapeutic solutions.
Conclusion
Andre Stoll's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in cardiovascular therapies, demonstrating the importance of innovation in medicine.